The management of chronic P. aeruginosa infections remains challenging due to the physiology and genetics of the organism. The QS cascade is an excellent target for design of novel drugs that could reduce the pathogenicity of P. aeruginosa, because QS is required for ex- . Although is an acyl-homoserine lactone (acyl-HSL). We initiated a study of the requirements for binding of the AI to some residues in the TraR crystal structure that directly interact with the AI are conserved in LasR, the overall its protein effector LasR by synthesizing a library of analogs with the HSL moiety replaced with different sequence identity between the two proteins is only 17%. Furthermore, the specificity determinants of each proamines and alcohols. We tested each compound for both agonist and antagonist activity using a QS-contein for its cognate AI are unknown. Unfortunately, the active LasR protein has yet to be purified due to technitrolled reporter gene assay and found several new agonists and antagonists. A representative antagonist cal challenges, and therefore we have little information about the LasR-AI1 interaction at the molecular level. was further tested for its ability to inhibit virulence factors. This data progresses our understanding of Hence, any knowledge regarding this interaction gained indirectly from studies, such as this one, would aid in the LasR-AI interaction toward the rational design of therapeutic inhibitors of QS. 
. While our primary goal is to find deep-well plate and dried under vacuum. inhibitors of QS, the library was also screened for agonist activity to gain more insight into the nature of the LasRLibrary Screening for Agonists AI1 interaction. Examination of agonist structures allows Screening of individual molecules for their ability to actius to infer which AI components are required for LasR vate LasR was conducted using P. aeruginosa PAO-JP2 activation. We discovered that for strong activation of (lasI, rhlI) [2] harboring plasmid plasI-LVAgfp [22] . Since LasR, a five-or six-membered ring with a hydrogen this strain lacks the ability to produce natural AIs due (H) bond acceptor adjacent to the amine of the HSL is to disruption of both AI synthase genes, activation of required. Furthermore, inhibition was achieved by comLasR relies on the addition of exogenous AI1. Exprespounds that maintained the hydrogen (H) bond acceptor sion of gfp (encoding green fluorescent protein) is under but contained an aromatic ring. A representative antagocontrol of the LasR-AI1 inducible lasI promoter, allowing nist was tested for its QS inhibition activity, and it sucrapid screening for LasR agonists by measuring the level cessfully reduced expression of LasR and RhlR conof GFP expression in their presence. trolled reporter genes and elastase.
Results of screening are shown in Figure 3 . Three strong agonists (D11, D12, and H3) and two weaker Results and Discussion agonists (C11, E11) were present in the library. The corresponding unconjugated amines were assayed, and no Library Synthesis agonist activity was observed (data not shown), indicatTo facilitate generation of the desired library, we immoing that the side chain is crucial for activity. Among the bilized the 3-oxo-C 12 side chain onto solid phase and three strong agonists identified is homocysteine thiolacrmed coupling with various amines and alcohols in paraltone (D11), which was included in the library as an interlel. We modified the terminus of the acyl chain with a nal control. This confirmed the reliability of the assay hydroxyl group and added an extra carbon atom (see system as well as the assumption that the OH modifica-13-OH-3-oxo-C 13 in Figure 3 ) for immobilization to a tion at the terminus of the acyl side chain does not 3,4-dihydro-2H-pyran (DHP) resin. Based on previous interfere with agonist activity. Interestingly, B11 and observations that shortening or extending the AI1 side G12, compounds very similar to D11, were not active. chain one or two carbons did not reduce its activity B11 is likely inactive due to the ␥-lactam ring structure significantly [16], we were confident that this modifica-(which is known to be nearly inactive) [16] and interfertion would not interfere with LasR binding. However, a ence of the oxygen substitution with putative hydrophopreviously identified HSL agonist, homocysteine thiolacbic interactions between the inducer and LasR. G12, tone [16], was included in the library to verify this aswhich has the HSL amide bond replaced with an ester, sumption and confirm the ability of our screening techis also inactive. This suggests that the amino group niques to identify agonists. The template molecule 2 is required for activity in P. aeruginosa. This data is (Figure 2) was synthesized in solution phase through a supported by the TraR-3-oxo-C 8 -HSL crystal structure three-step sequence in an overall yield of 38%. The that shows Asp70 (a residue conserved in LasR) in a H attachment of 2 to the DHP resin and on-resin hydrolysis bond with the HSL amino group. Obviously, this putative H bond cannot be maintained by compound G12. of the ester moiety proceeded successfully, as evi- One of the new agonist structures identified from the with both the lasI-gfp reporter as well as a lasB-lacZ reporter in Escherichia coli. E. coli strain MG4 harboring library, D12, is 2-aminocyclohexanol (Figure 3) . The hydroxyl group adjacent to the amino group in D12 is plasmid pKDT37 expresses lasR and contains a lacZ reporter gene controlled by a LasR-AI1 inducible lasB clearly important for activity, since similar molecules that lack the OH group at this position, such as compromoter [16]. Both of these reporter genes were activated in the presence of control AI1 or 3-oxo-C 12 -D12 pounds A12 and B12, show no activity. Interestingly, D12 shares two structural features with AI1: (1) the OH ( Figures 3C and 3D ), demonstrating that this agonist has LasR inducing activity comparable to the natural AI1. It group mimics the carbonyl group of HSL which participates in a hydrogen bond in the TraR crystal structure, also provides strong evidence that the agonist activity in P. aeruginosa is LasR dependent. with the highly conserved residue Trp57; and (2) the cyclohexane ring mimics the saturated ring structure of We were very interested in exploring the nature of D12's strong agonist activity further, so we synthesized HSL, presumably presenting appropriate hydrophobic contacts to LasR. 3-oxo-C 12 -D12, containing the natural a series of compounds with five-or six-membered saturated rings with H bond acceptors (hydroxyl or keto side chain, was synthesized in solution phase and tested group) at position 1. We found that 2-aminocyclohexanol and 2-aminocyclopentanone are agonists, but 2-aminocyclohexanone and 2-aminocyclopentanol are antagonists (see Figure 7) . These results are presented in previous work [23] and are discussed further below in relation to the current study.
The 
Library Screening for Antagonists
We tested each compound in the library for antagonist activity using the same reporter strain, PAO-JP2 (plasILVAgfp) [2], to find compounds that could compete against AI1 and reduce GFP expression. We identified eight compounds that inhibited reporter gene expression by greater than 50% ( Figure 4A ). None of the compounds exhibited an obvious affect on growth of the most interestingly it differs from the strong agonist D12 only by the aromatic ring ( Figure 3B ), we focused on We therefore conclude that the combination of an aniline structure and H bond acceptor dictates the antagonist D10 for further studies. We synthesized 3-oxo-C 12 -D10 in solution phase, where the natural side chain was couactivity of this set of molecules.
We also identified F11, G11, and E3 as antagonists, pled with D10 and purified by chromatography. To determine if the same structural motif can be applied to inhibibut these molecules do not have obvious structural connections to each other or the aniline antagonists distion of the RhlR-AI2 interaction, C 4 -D10 was also synthesized. Assays were performed with both the lasIcussed above. Therefore, these individual compounds need to be resynthesized in solution phase, and their gfp reporter PAO-JP2 (plasI-LVAgfp) and an RhlR-AI2- 
. This compound was also tested in virulence factor assays but uniformly showed no effect on their expression (data not shown).
To further confirm the ability of 3-oxo-C 12 -D10 to spe- exogenously ( Figure 5A ). This antagonist also reduced elastase activity produced by wild-type P. aeruginosa strain PAO1 ( Figure 5B ). These results suggest that Comparison between 3-Oxo-C 12 -D10 3-oxo-C 12 -D10 inhibits elastase production by P. aerugiand 3-Oxo-C 12 -(2-Aminocyclohexanone) nosa, and provide additional evidence that this comOur two studies described here and in a previous report pound specifically interferes with QS-controlled gene [23] yielded four new compounds that agonize or antagexpression. We also tested 3-oxo-C 12 -D10 for its effect onize the P. aeruginosa QS circuit (Figure 7) . Intereston pyocyanin production ( Figures 5C and 5D ), but this ingly, these molecules are structurally related to each compound was unable to interfere with pyocyanin producother: all compounds have a hydroxyl or keto group tion by either PAO-JP2 ( Figure 5C) or PAO1 (Figure 5D ). adjacent to the amino group and a five-or six-membered Finally, we tested the effect of this antagonist on bioring structure. A particularly intriguing discovery is that film development using a static biofilm assay with PAOa very subtle change to the agonist 3-oxo-C 12 -D12 JP2 and PAO1 harboring plasmid pTdK-GFP [22] which makes it an antagonist: the hydroxyl group to ketone encodes a constitutively expressed GFP construct for (3-oxo-C 12 -acHone), saturated ring to aromatic benzene visualization of cells by scanning confocal laser microsring (3-oxo-C 12 -D10), and six-to five-membered ring copy (Figures 6A-6E) . In PAO-JP2, formation of biofilm (3-oxo-C 12 -acPol). was dependent on the presence of exogenous AIs ( 
